Saol Therapeutics and GeneDx have partnered to identify patients with rare mitochondrial disease. There are currently no FDA-approved treatments for patients with PDCD so this is a huge step in the right direction:
Saol Therapeutics, GeneDx Partner to ID Patients With Rare Mitochondrial Disease
March 15th, 2022
